Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round

Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round

Source: Volodymyr Hryshchenko/Unsplash

Liya Su

22 December, 2021

Xbiome

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.